Public Profile

Viatris

Viatris Inc., a global healthcare company formed through the merger of Mylan and Upjohn, is headquartered in the United States. Established in 2020, Viatris operates in over 165 countries, focusing on the pharmaceutical industry with a commitment to providing access to high-quality medicines. The company’s core business areas include generic and specialty pharmaceuticals, biosimilars, and over-the-counter products. Viatris is renowned for its extensive portfolio, which features a diverse range of medications that address various health conditions, including chronic diseases and infectious diseases. Its unique approach combines a broad product offering with a strong emphasis on patient access and affordability. With a significant market presence, Viatris has achieved notable milestones, including the successful integration of its legacy companies and a commitment to sustainable healthcare solutions.

DitchCarbon Score

How does Viatris's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Viatris's score of 37 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.

94%

Viatris's reported carbon emissions

In 2023, Viatris reported total carbon emissions of approximately 751,600,000 kg CO2e, with 335,600,000 kg CO2e from Scope 1 and 416,100,000 kg CO2e from Scope 2. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2020 as the base year. Additionally, Viatris targets a 25% reduction in absolute Scope 3 emissions, which encompass purchased goods and services, capital goods, and upstream transportation and distribution, within the same timeframe. In the UK, Viatris has committed to achieving net zero emissions by 2050, further demonstrating its dedication to sustainability. The company has consistently disclosed its emissions across all relevant scopes, including Scope 1, 2, and 3, and has made significant strides in reducing its carbon footprint over the years. For instance, in 2020, total emissions were reported at approximately 781,400 kg CO2e, reflecting ongoing efforts to enhance operational efficiency and sustainability practices. Viatris's climate strategy aligns with industry standards and reflects a commitment to addressing climate change through measurable targets and transparent reporting.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201520162017201820192020202120222023
Scope 1
299,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
354,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
653,000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000,000
-
0,000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Viatris's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Viatris is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Viatris is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Sai Life Sciences

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Concord Biotech

IN
Fabricated metal products, except machinery and equipment (28)
Updated about 1 month ago

Regeneron

US
Research and development services (73)
Updated 5 days ago

Csl

AU
Health and social work services (85)
Updated 2 days ago

Sandoz

CH
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Shasun Pharmaceuticals Limited

IN
Chemicals nec
Updated 23 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers